Drug intelligence / Profile preview

cisplatin + dexamethasone + vitamin B12 + folic acid

Development stage
Unknown
Lead developer
Eli Lilly
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Intravenous, Oral, Intramuscular
01

Overview

This is a **combination regimen consisting of cisplatin, dexamethasone, vitamin B12, and folic acid**. Each component serves a distinct purpose: - **Cisplatin** is a platinum-based chemotherapeutic agent used primarily for various solid tumors by causing DNA crosslinking and apoptosis. - **Dexamethasone** is a synthetic glucocorticoid corticosteroid used to reduce chemotherapy-induced nausea, vomiting, and inflammation[2][6]. - **Vitamin B12** and **folic acid** are dietary supplements administered to reduce hematologic and non-hematologic toxicities associated with chemotherapy, especially important when used with antifolate chemotherapies like pemetrexed in regimens that often also include cisplatin[1][5][7]. This specific four-drug combination is not a standard combination therapy with a unique brand name, but the **co-administration of dexamethasone, vitamin B12, and folic acid is commonly recommended in protocols with pemetrexed/cisplatin** chemotherapy to minimize toxicity and side effects. Mechanistically, cisplatin acts through DNA crosslinking, dexamethasone acts via glucocorticoid receptor agonism to modulate immune and inflammatory responses and suppress nausea, while vitamin B12 and folic acid support DNA synthesis and repair, reducing chemotherapy-induced cytopenias and mucositis.

02

Targets

TS (Thymidylate synthase)GR (Glucocorticoid receptor)MTR (Methionine synthase)DHFR (Dihydrofolate reductase)DNAMMUT (Methylmalonyl-coenzyme A mutase)

Beyond the preview

Go deeper on cisplatin + dexamethasone + vitamin B12 + folic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cisplatin + dexamethasone + vitamin B12 + folic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call